Theodore James Jr. Washburn - Mar 1, 2023 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Principal Accounting Officer
Signature
/s/ William Cook, as attorney-in-fact for Theodore James Jr. Washburn
Stock symbol
AGIO
Transactions as of
Mar 1, 2023
Transactions value $
-$6,910
Form type
4
Date filed
3/3/2023, 03:08 PM
Previous filing
Feb 21, 2023
Next filing
Mar 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGIO Common stock Options Exercise $0 +777 +28.35% $0.00 3.52K Mar 1, 2023 Direct F1
transaction AGIO Common stock Tax liability -$6.91K -273 -7.76% $25.31 3.25K Mar 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Restricted stock units Award $0 +7.05K $0.00 7.05K Mar 1, 2023 Common stock 7.05K Direct F2, F3
transaction AGIO Restricted stock units Options Exercise $0 -777 -33.33% $0.00 1.55K Mar 1, 2023 Common stock 777 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 73 shares purchased through the Company's employee stock purchase plan.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
F4 The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.